Fantasy Football - Footballguys Forums
This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
Stock Thread (33 Viewers)
- Thread starter St. Louis Bob
- Start date
JoeSteeler
Footballguy
Big League Chew
Footballguy
that article seems relevant last month
Jefferson the Caregiver
Rebel Without A Pause
CNBC hates Cytodyn/Leronlimab. They won't pick up the story until their test results from the double blind trials prove effective.
fantasycurse42
Footballguy Jr.
needanap
Footballguy
I would be pleasantly surprised if it is published tomorrow, but based on looking at a few articles published in Nature they seem to take a couple of months from time of submission to being published. The paper is probably following the typical path and time frame, but we get the impression it is "slow" or "delayed" due to CYDY getting a head of themselves by saying it would be published soon.
Moonlight
Footballguy
Everything turns on this. If effective will be recognized everywhere expect Trump will join the chorus.
fantasycurse42
Footballguy Jr.
In 2 hours today, the market fell 1% rose 1% and has fallen over 1%
####### Stonks
####### Stonks
Don Hutson
Footballguy
It's been suggested that it could be published faster than normal because of the urgency of the pandemic. But that could just be wishful thinking.
beef
Footballguy
JETS about to retest the lows. That's been a new investors Robinhood favorite from data they've posted.
I only have a small stake in JETS and will consider doubling down. But not yet.
fantasycurse42
Footballguy Jr.
Should have stayed in it but keeps getting halted.
McBokonon
Footballguy
Todem
Footballguy
IMO we can trade this thing for 20-30% gains every other week. Same with MGM. With reopening's....we will get this kind of quick hit action up and down.
Last edited by a moderator:
McBokonon
Footballguy
"Creative Realities" sounds like an unpublished Ken Kesey novel.
Stonks Go Down
-OZ-
Footballguy
Stonks go bounce.In 2 hours today, the market fell 1% rose 1% and has fallen over 1%
####### Stonks
Sold half my JETS a while ago, might add soon.
Shoulda sold PK when it first rose
ghostguy123
Footballguy
Todem
Footballguy
No one wants to hear this one.....but I added some more BA here to my own account (just a little more). My 12 month price target is now in the $260 range. When the Max get’s re-certified some time this summer this baby will pop hard. I see more tailwinds for BA then headwinds.Added some MGM at 12.77.
What else ya got?
Last edited by a moderator:
Todem
Footballguy
Yeah, that's too long a time frame for my A-trade gambling account. I'm sure I'll have plenty in my 457b when I get back in.
cosjobs
Footballguy
CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020
BY GlobeNewswire
— 6:00 AM ET 05/13/2020
CytoDyn Submits Requested Datasets to FDA for Biologics License Application
VANCOUVER, Washington, May 13, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today confirmed on May 11, 2020, it submitted all remaining parts of the Company’s Biologics License Application (“BLA”) for leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients to the U.S. Food and Drug Administration (“FDA”). Pursuant to FDA guidelines, CytoDyn informed the FDA it had submitted a complete BLA for rolling review.
As a next step, the FDA will start reviewing the BLA for completeness and will make a filing decision. After the BLA submission is deemed completed, the FDA assigns a Prescription Drug User Fee Act (PDUFA) goal date. CytoDyn has Fast Track designation for leronlimab and a rolling review for its BLA, as previously assigned by the FDA, and the Company plans to request a priority review for the BLA. A priority review designation, if granted, means the FDA’s goal is to take action on the application within six months of receipt (compared with 10 months under standard review).
BY GlobeNewswire
— 6:00 AM ET 05/13/2020
CytoDyn Submits Requested Datasets to FDA for Biologics License Application
VANCOUVER, Washington, May 13, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today confirmed on May 11, 2020, it submitted all remaining parts of the Company’s Biologics License Application (“BLA”) for leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients to the U.S. Food and Drug Administration (“FDA”). Pursuant to FDA guidelines, CytoDyn informed the FDA it had submitted a complete BLA for rolling review.
As a next step, the FDA will start reviewing the BLA for completeness and will make a filing decision. After the BLA submission is deemed completed, the FDA assigns a Prescription Drug User Fee Act (PDUFA) goal date. CytoDyn has Fast Track designation for leronlimab and a rolling review for its BLA, as previously assigned by the FDA, and the Company plans to request a priority review for the BLA. A priority review designation, if granted, means the FDA’s goal is to take action on the application within six months of receipt (compared with 10 months under standard review).
Last edited by a moderator:
fantasycurse42
Footballguy Jr.
Try to keep this as unpolitical as possible:
When you see Trump tweeting about the stock market (such as today or on February 28th), he's prob getting the heads up from Mnuchin or someone similar that stonks are about to fall. He gets nervous and tries jawboning, like he did today. I'd be careful in those situations.
When you see Trump tweeting about the stock market (such as today or on February 28th), he's prob getting the heads up from Mnuchin or someone similar that stonks are about to fall. He gets nervous and tries jawboning, like he did today. I'd be careful in those situations.
ghostguy123
Footballguy
NREC34
Footballguy
, but I'm holding
Random
Footballguy
![[icon]](/data/avatars/m/5/5167.jpg?1660313464){kind=avatar}
Bob Sacamano
Footballguy
ghostguy123
Footballguy
Lil more at 9.03.
They goin out of business or something? I want some steak and sides Billy right now.
Cost basis 9.18 now.
Hey Todem why the optimism specifically got BLMN to rise up soon again?
Last edited by a moderator:
He said only 1999 was more overvalued than now and he's only 10-15% long equities. You've come way down on your optimism but I don't think you're quite on that level.
Todem
Footballguy
LOL hell no!!! Tepper is really bearish. I am bearish for 2020. This market is too high right now no doubt.He said only 1999 was more overvalued than now and he's only 10-15% long equities. You've come way down on your optimism but I don't think you're quite on that level.
But I agree with his thoughts to a lesser extreme. He is a very active manager. Far more than I am.
My most conservative clients are 50-60% CASH. Everyone else is 30% (which is the majority of my book of business).
fantasycurse42
Footballguy Jr.
I added to my JPM position today. Honestly, don't love it, but whatever. I would try to talk you off of BAC though.
Todem
Footballguy
JPM is the only bank I own. It will be more of a dividend play here for a few years. Nice yield with some growth come 2022 2023. We hope. They are extremely conservative in the lending department.
Last edited by a moderator:
